Today, Redox, the industry-leading platform accelerating healthcare data exchange, announced that Simon Parmett has joined the Redox Board of Directors as an independent board member. This disclosure arrives one year after Redox announced its MuleSoft Connector, which enables bidirectional integration for all Redox data models across the Anypoint Platform™.
At MuleSoft, Parmett led the company from a 40-person team with less than $10 million in revenue to a more than 3,000 person global leader with more than $1 billion in revenue. His addition to the Redox board comes as the scaling company expands its offering.
Also Read: The Evolving World of B2B Marketing Strategies
Parmett and Redox mutual spheres of expertise:
- expediting industry-wide interoperability to unlock customer scale,
- navigating specialized regulatory & security requirements,
- defining a centralized API-based platform for data exchange.
When asked why he joined the Redox board, Parmett revealed, “When I think about what makes a generational company, it means attacking a massive problem and establishing a solution that transcends generations. That’s what Redox is doing. Healthcare interoperability and integration is, perhaps, the world’s biggest problem because it hits every person. Redox’s track record of both vision and follow-through proves them uniquely capable of getting the job done.”
“Simon’s work sets the stage for MuleSoft to navigate the hurdles that come with significant scale,” Redox CEO Luke Bonney shares. “Redox is positioned on a similar trajectory. Simon’s strategic contribution is not that we simply replicate any steps he’s seen before, but rather he presents the context that allows us to solve the biggest challenges and opportunities together.”
